This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies

Hsien-Yuan Lane and Wen-Ho Chang

Published: July 1, 1999

Article Abstract

Letter to the Editor

Sir: We read with interest the recent article by Lindenmayer et al. concerning the comparison of clozapine versus risperidone in 35 treatment-refractory schizophrenic patients. In the 12-week open-label study, both medications were effective across a wide spectrum of psychopathologic measures, with clozapine being numerically superior to risperidone. In addition, clozapine was associated with fewer extrapyramidal side effects.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: